Short Float History | News | Indicators | Short Stats | Earnings History | Technical Averages | RXII Yahoo Finance Page

RXII RXi Pharmaceuticals Corporation

Note: We have detected that our data provider shows 0 for short interest. Please manually confirm and if different, disregard the short data and short pain data below.

$0.3455 -20.21%

4,789,423 Shares Traded
2,120,818 Average Volume (last 30 days)

as of 3:44:59 PM EST IEX Real-Time Price

Click Here to Short Float History Versus Price & Peer Short Floats

Free Newsletter Sign Up


RXi Pharmaceuticals to Present New Data Demonstrating the Ability of sd-rxRNA to Enhance NK Cell Activity for Adoptive Cell Transfer at SITC 2018 (PR Newswire)

Short Pain Metrics

Approximate Amount of Money Shorts Have Lost on the Day: $0
If Intiated on the First, Shorts Have Realized a Year to Date Return of:92.13%
If Intiated One Month Ago, Shorts Have Realized a Return of:18.3%
If Initiated Five Days ago, Shorts Have Realized a Return of:-1%
Peer Rising Stocks Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points.

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 0%
Short Interest0
Float7.04 million
Short Ratio0
Market Cap$3.52 million
Market Maker ActivityDaily Short Volume

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 9.3%
Insider Percent44.5%

Earnings Stats

PE Ratio -0.1
Dividend Yield 0%

Earnings History For RXII

Earnings DateQuarterConsensus EPSActual EPSEPS Surprise
2018-08-14 AMCQ2 2018-0.59 (2 Estimates) -0.460.13
2018-05-10 AMCQ1 2018-0.9
2018-03-26 AMCQ4 2017-0.96 (1 Estimates) -0.840.12
2017-11-08 AMCQ3 2017-1.1 (1 Estimates) -1.1


200 Day Moving Average $2.15
50 Day Moving Average $0.83
52 Week High $7.7
52 Week Low $0.4

Back to the Top

Data provided for free by IEX. Questions? Read the FAQ